Date | Opp | DKSAL | FDSAL | DKFPTS | FDFPTS | fuml | ruypc | att | 2ptpa | payds | patd | krtd | int | 2ptre | ruatt | tchs | ruyds | cmp | rutd | putd | tar | fumtd | rec | 2ptru | rzatt | pct | rztar | reypc | reyds | tyds | retd |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-17 | @ DET | $5.2K | $5.9K | 7.8 | 5.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 7 | 0 | 5 | 0 | 0 | 0 | 0 | 71.4 | 28 | 28 | 0 |
2024-11-10 | vs. MIN | $5.3K | $6.2K | 10 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 8 | 0 | 6 | 0 | 0 | 0 | 0 | 75 | 40 | 40 | 0 |
2024-11-03 | @ PHI | $5.3K | $6.4K | 11.5 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 5 | 0 | 0 | 0 | 0 | 10 | 0 | 5 | 0 | 0 | 0 | 0 | 50 | 45 | 45 | 0 |
2024-10-27 | vs. GB | $5K | $6.2K | 13.6 | 11.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 5 | 0 | 4 | 0 | 0 | 0 | 0 | 80 | 36 | 36 | 1 |
2024-10-20 | vs. NE | $4.9K | $6.6K | 8.5 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 5 | 0 | 5 | 0 | 0 | 0 | 0 | 100 | 35 | 35 | 0 |
2024-10-13 | @ CHI | $4.7K | $5.8K | 22.2 | 16.2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 10 | 0 | 10 | 0 | 0 | 0 | 0 | 100 | 102 | 102 | 0 |
2024-10-06 | vs. IND | $4.6K | $5.8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-09-29 | @ HOU | $4.6K | $5.8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-09-23 | @ BUF | $4.9K | $5.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-09-15 | vs. CLE | $5.4K | $5.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-09-08 | @ MIA | $5.5K | $6.2K | 1.5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 | 0 | 1 | 0 | 0 | 0 | 0 | 25 | 5 | 5 | 0 |
2024-08-23 | @ ATL | $5.5K | $6K | 18.8 | 16.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 100 | 28 | 28 | 2 |
2024-08-17 | vs. TB | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-08-10 | vs. KC | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-01-07 | @ TEN | $5.4K | $6.8K | 23.9 | 18.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 13 | 0 | 10 | 0 | 0 | 0 | 0 | 76.9 | 79 | 79 | 1 |
2023-12-31 | vs. CAR | $5.7K | $7K | 12 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 6 | 0 | 6 | 0 | 0 | 0 | 0 | 100 | 60 | 60 | 0 |
2023-12-24 | @ TB | $5.4K | $6.3K | 18.5 | 12.5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 15 | 0 | 10 | 0 | 0 | 0 | 0 | 66.7 | 95 | 95 | 0 |
2023-12-17 | vs. BAL | $5.4K | $6.1K | 6.8 | 4.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 6 | 0 | 4 | 0 | 0 | 0 | 0 | 66.7 | 28 | 28 | 0 |
2023-12-10 | @ CLE | $4.8K | $5.7K | 32.5 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 12 | 0 | 11 | 0 | 0 | 0 | 0 | 91.7 | 95 | 95 | 2 |
2023-12-04 | vs. CIN | $4.5K | $5.6K | 23.2 | 18.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 9 | 0 | 9 | 0 | 0 | 0 | 0 | 100 | 82 | 82 | 1 |
2023-11-26 | @ HOU | $4.2K | $5.8K | 9.9 | 7.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 8 | 0 | 5 | 0 | 0 | 0 | 0 | 62.5 | 49 | 49 | 0 |
2023-11-19 | vs. TEN | $4.3K | $5.7K | 6.9 | 4.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 6 | 0 | 4 | 0 | 0 | 0 | 0 | 66.7 | 29 | 29 | 0 |
2023-11-12 | vs. SF | $4.5K | $5.6K | 5.2 | 3.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 7 | 0 | 4 | 0 | 0 | 0 | 0 | 57.1 | 12 | 12 | 0 |
2023-10-29 | @ PIT | $4.5K | $5.7K | 17.8 | 11.8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 10 | 0 | 10 | 0 | 0 | 0 | 0 | 100 | 88 | 88 | 0 |
2023-10-19 | @ NO | $4.5K | $5.7K | 9.5 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 7 | 0 | 5 | 0 | 0 | 0 | 0 | 71.4 | 45 | 45 | 0 |
2023-10-15 | vs. IND | $4.5K | $5.5K | 11.1 | 7.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 7 | 0 | 7 | 0 | 0 | 0 | 0 | 100 | 41 | 41 | 0 |
2023-10-08 | @ BUF | $4.7K | $5.6K | 6.8 | 4.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 8 | 0 | 4 | 0 | 0 | 0 | 0 | 50 | 28 | 28 | 0 |
2023-10-01 | vs. ATL | $4.7K | $5.6K | 12.9 | 9.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 8 | 0 | 7 | 0 | 0 | 0 | 0 | 87.5 | 59 | 59 | 0 |
2023-09-24 | vs. HOU | $4.8K | $5.9K | 13.7 | 10.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 8 | 0 | 7 | 0 | 0 | 0 | 0 | 87.5 | 67 | 67 | 0 |
2023-09-17 | vs. KC | $4.8K | $6K | 11.7 | 8.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 8 | 0 | 6 | 0 | 0 | 0 | 0 | 75 | 57 | 57 | 0 |
2023-09-10 | @ IND | $4.7K | $5.8K | 9.9 | 7.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 5 | 0 | 5 | 0 | 0 | 0 | 0 | 100 | 49 | 49 | 0 |
2023-08-26 | vs. MIA | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-08-19 | @ DET | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-08-12 | @ DAL | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-21 | @ KC | $4.3K | $6K | 8.1 | 5.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 6 | 0 | 5 | 0 | 0 | 0 | 0 | 83.3 | 31 | 31 | 0 |
2023-01-14 | vs. LAC | $4.4K | $5.7K | 22.3 | 18.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 11 | 0 | 7 | 0 | 0 | 0 | 0 | 63.6 | 93 | 93 | 1 |
2023-01-07 | vs. TEN | $4.5K | $5.8K | 6.7 | 4.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 100 | 27 | 27 | 0 |
2023-01-01 | @ HOU | $4.4K | $5.8K | 3.9 | 3.4 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 13 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 50 | 16 | 29 | 0 |
2022-12-22 | @ NYJ | $3.9K | $5.5K | 21.3 | 14.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 8 | 0 | 7 | 0 | 0 | 0 | 0 | 87.5 | 113 | 113 | 0 |
2022-12-18 | vs. DAL | $3.8K | $5.5K | 14.2 | 10.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 10 | 0 | 8 | 0 | 0 | 0 | 0 | 80 | 62 | 62 | 0 |
2022-12-11 | @ TEN | $3.3K | $5.1K | 42.2 | 33.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 15 | 0 | 11 | 0 | 0 | 0 | 0 | 73.3 | 162 | 162 | 2 |
2022-12-04 | @ DET | $3K | $4.8K | 14 | 11.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 7 | 0 | 5 | 0 | 0 | 0 | 0 | 71.4 | 30 | 30 | 1 |
2022-11-27 | vs. BAL | $3.2K | $4.9K | 1.4 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 100 | 4 | 4 | 0 |
Evan Engram Daily Fantasy News, Rankings, Projections
Evan Engram (hamstring) unlikely to play Sunday.
Evan Engram (hamstring) unlikely to play Sunday.
Evan Engram (hamstring) has been ruled inactive. Injured in warm-ups.
Evan Engram (hamstring) has been ruled inactive. Injured in warm-ups.
JAC TE Evan Engram (back) was limited at practice Thursday.
JAC TE Evan Engram (back) was limited at practice Thursday.
JAC TE Evan Engram (back) was limited at practice Wednesday.
JAC TE Evan Engram (back) was limited at practice Wednesday.
NYG RB Saquon Barkley, WR Kenny Golladay DNP Friday; WR Kadarius Toney, WR Sterling Shepard, and TE Evan Engram all limited
The Giants skill position players have been decimated by injury, but should be improved from last week as they prepare for MNF against the reeling Chiefs. Saquon and Golladay were both held out again, and are likely going to be ruled out tomorrow; both players were projected to only miss one week, but may be on their third coming up. Toney looked a lot better in practice and was able to get in a limited session; he appears to be on his way back, along with Shepard, who was ruled out last week. Engram was also limited, although his name has been on the trade block for teams across the league. The biggest beneficiary should any WRs sit would be Dante Pettis, who played well and scored 15.54 DK points due to the absence of all the receivers, but with Toney and Shepard looking promising, it'll likely be those two who get the bulk of the targets.
NYG RB Saquon Barkley (ankle), WR Kenny Golladay (knee), and WR Kadarius Toney (ankle) DNP Thursday; TE Evan Engram (calf) and WR Sterling Sheaprd (hamstring) both limited
The Giants lengthy injury report continues as arguably their five top options are still hurting as they prepare for MNF against the KC Chiefs. Saquon, Golladay, Toney, all missed last game and all couldn't practice today, although Joe Judge has optimism and thinks they may be closer than it seems. Shepard also missed last game, but was able to get a limited session in, along with Engram. Since they play on Monday, tomorrow and Saturday's practice will be far more important.
NYG WR Sterling Shepard inactive; WR Darius Slayton, WR John Ross, TE Evan Engram all active Sunday
Darius Slayton, John Ross, and Evan Engram are all available to play Sunday against the Carolina Panthers while Sterling Shepard will not be able to suit up due to a hamstring injury. The Giants will at least have two of their injured receivers available today along with their starting tight end, which is good news in what could be a huge bounce back game for the Giants. However, with Shepard unable to go, Darius Slayton becomes the top receiving option and a good value option with Engram also seeing a bump. It is tough to distinguish between what pieces are usable in the Giants offense at this point and with a tough matchup against a good Panthers defense it might just be best to stay away now that Shepard has been ruled out.
NYG WR Darius Slayton, WR John Ross, and TE Evan Engram are expected to play Sunday; WR Sterling Shepard will be a game-time decision
Darius Slayton, John Ross, and Evan Engram are expected to play Sunday against the Carolina Panthers while Sterling Shepard will be a game-time decision with a hamstring injury. The Giants will at least have two of their injured receivers available today along with their starting tight end, which is good news in what could be a huge bounce back game for the Giants. Sterling Shepard still remains questionable and will have to go through warmups before a decision is made on his availability. Shepard projects as one of the better plays on the slate due to his expected volume. However if he were unable to go, Darius Slayton would become the top receiving option with Engram also seeing a bump. It is tough to distinguish between what pieces are usable in the Giants offense at this point and with a tough matchup against a good Panthers defense it might just be best to stay away if Shepard is unable to suit up.
NYG RB Saquon Barkley, WR Kenny Golladay, WR Kadarius Toney ruled out Sunday; WR Sterling Shepard, WR Darius Slayton, WR John Ross, TE Evan Engram questionable
As expected, Saquon Barkley, Kenny Golladay, and Kadarius Toney have been ruled out for Sunday's matchup with the Carolina Panthers. Sterling Shepard, Darius Slayton, John Ross, and Evan Engram are considered questionable. Devontae Booker is likely set to lead the Giants' backfield once again Sunday with Elijhaa Penny and Gary Brightwell available to back him up. Booker was able to rush for 41 yards on 12 carries last Sunday and caught all 4 of his targets for an additional 28 yards in a tough matchup with the Los Angeles Rams and can be considered a value option again this week. Shepard is expected to garner a large target share (if available) with Slayton expected to serve as the number two option (again, if available). Ross and Dante Pettis are also expected to mix in, though Shepard is the primary DFS target based on his expected volume in a matchup where the Giants are likely going to need to pass the ball to have any success.
NYG TE Evan Engram, WR Kenny Golladay, WR Kadarius Toney, and RB Saquon Barkley all DNP Thursday; WR Darius Slayton and WR Sterling Shepard limited
The Giants had a loaded injury report once again, with even more bad news than yesterday. Barkley, Golladay, and Toney all had their second straight DNP; Barkley and Toney are almost certainly going to sit, while Golladay feels closer to doubtful than anything. Engram was added to the injury report with a calf injury, and was a DNP; he missed the first few games of the year with a calf issue, so it's a worrisome sign for sure. Slayton and Shepard were both limited but should be good to; Shepard played last week, while Slayton was ruled out last minute and seems close as well. Assuming that everyone that DNP ends up sitting, it'll be a huge target share for Shepard, with Slayton likely the second option. John Ross and Dante Pettis would mix in as well, but Shepard would be one of the best plays due to his target projection. Tomorrow's practice will hopefully give a more clear picture on what the situation will be for the Giants.